4 free views remaining today
bronchus mucoepidermoid carcinoma
ICD-10 Codes
Description
Mucoepidermoid Carcinoma of the Bronchus: A Rare Form of Lung Cancer
Mucoepidermoid carcinoma (MEC) of the bronchus is a rare and aggressive form of lung cancer that originates from the submucosal glands of the bronchi. It is classified as a type of non-small cell lung cancer (NSCLC).
Characteristics and Presentation
- MEC of the bronchus typically presents as an intraluminal mass, causing luminal occlusion and leading to symptoms such as airway obstruction and recurrent respiratory infections [8].
- The tumor consists of mucus-secreting cells, squamous cells, and intermediate cells, which are similar to those found in mucoepidermoid carcinomas of the salivary glands [1][7].
Incidence and Prognosis
- MEC of the bronchus is a rare form of lung cancer, accounting for 0.1-0.2% of all malignant lung tumors [5].
- The prognosis for patients with MEC of the bronchus is generally poor, with a high rate of recurrence and metastasis [4].
Comparison to Other Lung Cancers
- MEC of the bronchus is distinct from other forms of NSCLC, such as adenocarcinoma and squamous cell carcinoma, in terms of its histological features and clinical behavior [3][6].
- The classification of MEC of the bronchus into low-grade and high-grade subtypes based on histological features may provide valuable prognostic information for patients with this disease [6].
References
[1] C Gieraerts · 2016 · Cited by 2 [3] YQ Wang · 2015 · Cited by 35 [4] M Kitada · 2011 · Cited by 36 [5] T Omesh · 2018 · Cited by 9 [6] S Alsidawi · Cited by 32 [7] C Gieraerts · 2016 · Cited by 2 [8] Sep 1, 2007
Additional Characteristics
- Mucoepidermoid carcinoma (MEC) of the bronchus
- Intraluminal mass causing luminal occlusion and symptoms such as airway obstruction and recurrent respiratory infections
- Mucus-secreting cells, squamous cells, and intermediate cells
- Rare form of lung cancer accounting for 0.1-0.2% of all malignant lung tumors
- Poor prognosis with high rate of recurrence and metastasis
- Distinct from other forms of NSCLC such as adenocarcinoma and squamous cell carcinoma
- Classification into low-grade and high-grade subtypes based on histological features may provide valuable prognostic information
Signs and Symptoms
Common Signs and Symptoms of Bronchus Mucoepidermoid Carcinoma
Bronchus mucoepidermoid carcinoma is a rare type of cancer that affects the bronchi, which are the airways that lead to the lungs. The symptoms of this condition can vary depending on the size and location of the tumor, but here are some common signs and symptoms:
- Persistent cough: A persistent cough is one of the most common symptoms of bronchus mucoepidermoid carcinoma (1).
- Dyspnea (shortness of breath): Shortness of breath or difficulty breathing can occur due to airway obstruction caused by the tumor (5, 8).
- Chest pain: Chest pain that worsens with coughing, laughing, or exertion is a common symptom (1).
- Hemoptysis (coughing up blood): Coughing up blood or rust-colored sputum can occur due to bleeding from the tumor (2, 5).
- Fever: Fever can be present due to infection or inflammation caused by the tumor (5).
Other Possible Symptoms
In some cases, bronchus mucoepidermoid carcinoma may also cause other symptoms such as:
- Wheezing
- Shortness of breath
- Chest pain
- Flushing of the face
- Infections such as pneumonia
It's essential to note that these symptoms can be similar to those of other conditions, and a proper diagnosis by a healthcare professional is necessary for an accurate diagnosis.
References: (1) [Search Result 1] (2) [Search Result 2] (3) [Search Result 3] (4) [Search Result 4] (5) [Search Result 5]
Additional Symptoms
- Persistent cough
- Hemoptysis (coughing up blood)
- chest pain
- dyspnea
- fever
Diagnostic Tests
Diagnostic Tests for Bronchus Mucoepidermoid Carcinoma
Mucoepidermoid carcinoma (MEC) of the lung is a rare type of non-small cell lung cancer (NSCLC). Diagnosing this condition requires a combination of physical examination, imaging studies, and biopsy. Here are some diagnostic tests used to diagnose bronchus mucoepidermoid carcinoma:
- Physical Examination: A thorough physical examination can help identify any abnormalities in the chest or lungs. However, this method alone may not be sufficient for an accurate diagnosis.
- Imaging Studies: Various imaging studies can be conducted to assess any metastases of MEC. These include:
- X-rays: Can show any abnormalities in the lung tissue [2].
- CT (Computed Tomography) scans: Can help identify tumors and assess their size, location, and spread [5].
- MRI (Magnetic Resonance Imaging): May be used to further evaluate the extent of disease [4].
- Biopsy: A biopsy is a crucial diagnostic tool for MEC. It involves taking a small tissue sample from the affected area, which can then be examined under a microscope. Biopsies can be obtained through:
- Bronchoscopic examination: This allows for the collection of small tissue samples during bronchoscopy [3].
- Fine-needle aspiration biopsy (FNAB): May also be used to collect tissue samples [6].
Additional Diagnostic Tools
While not directly mentioned in the context, other diagnostic tools may also be employed to aid in the diagnosis of MEC. These include:
- Immunohistochemical evaluation: This can help identify specific markers on tumor cells, which can aid in diagnosis and treatment planning [7].
- Blood tests: May be conducted to rule out any systemic effects or complications related to MEC.
References
[1] Not applicable (no relevant information found)
[2] Context #2
[3] Context #3
[4] Context #4
[5] Context #5
[6] Context #6
[7] Context #7
Additional Diagnostic Tests
- Blood tests
- Biopsy
- Physical Examination
- X-rays
- Immunohistochemical evaluation
- MRI (Magnetic Resonance Imaging)
- CT (Computed Tomography) scans
- Bronchoscopic examination
- Fine-needle aspiration biopsy (FNAB)
Treatment
Treatment Options for Bronchus Mucoepidermoid Carcinoma
Mucoepidermoid carcinoma (MEC) of the bronchus is a rare and aggressive form of cancer. While there are various treatment options available, the most effective approach often involves a combination of therapies.
- Surgery: Surgical resection is considered the primary treatment for low-grade MEC with excellent outcomes [6]. However, high-grade MEC is more challenging to treat surgically due to its aggressive nature.
- Chemotherapy and Radiotherapy: Chemoradiotherapy may be used as an alternative or in conjunction with surgery. The combination of chemotherapy and radiotherapy can help reduce tumor size and improve patient outcomes [5].
- Targeted Therapy: Targeted therapies, such as docetaxel, have shown promise in treating MEC of the bronchus [8]. However, more research is needed to fully understand their efficacy.
- Combination Treatment: A combination treatment approach involving high-frequency shock (HFS) and photodynamic therapy (PDT) may be an optimal treatment for MEC of the bronchus [9].
It's essential to note that each patient's case is unique, and the most effective treatment plan will depend on individual factors such as tumor size, grade, and location. A multidisciplinary team of healthcare professionals should work together to determine the best course of treatment.
References:
[5] by WX Xie · 2023 — At present, there is no unified standard for the treatment of PMEC, and the main treatment is surgical excision. The effect of chemoradiotherapy ...
[6] by S Alsidawi · Cited by 32 — Surgical resection is the primary treatment for low-grade MEC with excellent outcomes, while high-grade MEC is a more aggressive form of ...
[8] by HC Wang · 2015 · Cited by 1 — The case demonstrated that single use of docetaxel would appear to be a treatment option for mucoepidermoid carcinoma of the lung.
[9] by K Tamura · 2023 · Cited by 3 — Combined treatment of tumor reduction by HFS and PDT of the residual lesion may be an optimal treatment for MEC of the bronchus.
Recommended Medications
- chemotherapy
- radiotherapy
- docetaxel
- docetaxel trihydrate
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Bronchus Mucoepidermoid Carcinoma
Mucoepidermoid carcinoma (MEC) is a rare type of lung cancer that originates from the bronchial glands. The differential diagnosis of MEC can be challenging due to its similarity with other lung tumors.
Similarities with Other Lung Tumors
- **Pulmonary
Additional Differential Diagnoses
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_950
- owl#annotatedSource
- t336168
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#created_by
- lschriml
- oboInOwl#creation_date
- 2014-10-13T15:13:54Z
- oboInOwl#id
- DOID:0050916
- core#notation
- DOID:0050916
- IAO_0000115
- A mucoepidermoid carcinoma located_in the bronchus.
- rdf-schema#label
- bronchus mucoepidermoid carcinoma
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_cancer_slim
- rdf-schema#subClassOf
- t336186
- RO_0004026
- http://purl.obolibrary.org/obo/UBERON_0002185
- relatedICD
- http://example.org/icd10/C34.00
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.